$256.00
TIRZ is a dual incretin receptor research peptide that interacts with both GIP and GLP-1 signaling pathways. In laboratory and pre-clinical research settings, this compound is studied for its role in metabolic regulation, insulin signaling dynamics, and energy balance mechanisms. Ongoing scientific investigation also explores how dual incretin activation may influence cardiometabolic markers and body-weight–related pathways under controlled experimental conditions.
GLP-2 is a specialized research peptide that provides insight into the relationship between intestinal health and systemic metabolism. By supporting studies in gut integrity, nutrient absorption, and metabolic efficiency, GLP-2 expands the scope of incretin research beyond appetite and insulin signaling.
Amino Pharm’s GLP-2 (T) is manufactured in the United States, verified for purity and identity, and supported by transparent documentation. It is designed for researchers who require precision, consistency, and confidence in their experimental materials.
GLP-2 is a naturally occurring glucagon-like peptide involved in gastrointestinal growth, nutrient absorption, and intestinal barrier regulation. In research settings, GLP-2 is studied for its role in maintaining gut integrity, influencing mucosal repair mechanisms, and supporting metabolic signaling pathways linked to nutrient utilization.
Amino Pharm supplies GLP-2 (T) as a research-grade peptide, manufactured in the United States and verified through third-party analytical testing. This compound is intended strictly for laboratory research and biochemical investigation by qualified professionals.
GLP-2 is co-secreted with GLP-1 from enteroendocrine L-cells in response to nutrient intake. Unlike GLP-1, which primarily influences insulin secretion and appetite signaling, GLP-2 is more closely associated with intestinal growth, epithelial maintenance, and absorptive capacity.
Because of these properties, GLP-2 has become a valuable research tool in studies focused on:
Gastrointestinal physiology
Nutrient absorption and utilization
Gut barrier integrity and permeability
Metabolic adaptation and energy efficiency
Intestinal inflammation and repair mechanisms
GLP-2 research provides insight into how the gut contributes to systemic metabolic balance and how intestinal signaling interacts with broader endocrine pathways.
Classification: GLP-2 receptor agonist
Primary Research Focus: Gastrointestinal and metabolic signaling
Mechanistic Target: GLP-2 receptors expressed in intestinal and enteric tissues
Purity Standard: ≥99% verified by HPLC
Manufacturing: U.S.-based production with batch-specific COA documentation
Each batch is identity-confirmed and tested for purity, ensuring reproducibility across experimental models.
In laboratory models, GLP-2 binds to GLP-2 receptors located primarily in the gastrointestinal tract. Receptor activation initiates signaling cascades that influence:
Intestinal epithelial cell proliferation
Mucosal thickness and surface area
Tight junction stability and barrier integrity
Nutrient transport efficiency
Local inflammatory signaling pathways
Through these mechanisms, GLP-2 is frequently used to study how intestinal health impacts metabolic efficiency, nutrient availability, and systemic energy balance.
GLP-2 is widely studied for its role in maintaining intestinal architecture. Researchers examine how GLP-2 signaling affects villus height, crypt depth, and epithelial regeneration under conditions of stress, nutrient deprivation, or inflammation.
This research is particularly relevant in models investigating gut adaptation, recovery, and long-term intestinal resilience.
GLP-2 research often focuses on how enhanced intestinal function may influence nutrient uptake. By improving absorptive surface area and transport efficiency, GLP-2 signaling may alter how carbohydrates, fats, and amino acids are processed at the gut level.
These studies contribute to broader metabolic research, including investigations into energy balance and nutrient partitioning.
Another major area of GLP-2 research involves intestinal permeability and immune signaling. GLP-2 is used to explore how gut barrier integrity affects systemic inflammation, endotoxin translocation, and metabolic stress responses.
Researchers studying metabolic syndrome, inflammatory bowel models, or nutrient-related immune activation frequently incorporate GLP-2 into experimental designs.
While GLP-2 is not primarily an appetite-modulating peptide, it is sometimes included in weight-related research frameworks to understand how intestinal efficiency and nutrient absorption influence body composition over time.
In this context, GLP-2 appears in studies alongside other weight loss peptides to evaluate indirect metabolic contributions rather than direct satiety signaling.
GLP-2 differs significantly from GLP-1 and dual incretin agonists:
GLP-1: Primarily influences insulin secretion and appetite regulation
GLP-2: Focuses on intestinal growth, absorption, and barrier maintenance
Dual agonists (GLP-1/GIP): Target combined metabolic and endocrine pathways
Because of this distinction, GLP-2 is often used in complementary research designs where gut-centric mechanisms are isolated from appetite-driven effects.
Every GLP-2 (T) peptide from Amino Pharm includes:
Batch-specific Certificate of Analysis (COA)
Identity confirmation via mass spectrometry
Purity verification by HPLC
Controlled manufacturing and packaging processes
This documentation supports reproducibility and compliance for academic, institutional, and private research laboratories.
GLP-2 is studied for its role in intestinal growth, nutrient absorption, and gut barrier integrity. It is commonly used in gastrointestinal and metabolic research models.
No. Although both are incretin peptides, GLP-2 primarily affects intestinal tissues, while GLP-1 targets insulin secretion and appetite signaling.
GLP-2 is sometimes included in metabolic and weight-related studies to understand how intestinal efficiency influences energy balance. It does not directly suppress appetite in research models.
No. Amino Pharm supplies GLP-2 strictly for laboratory research use. It is not approved for therapeutic, diagnostic, or veterinary applications.
Each batch undergoes third-party analytical testing, including HPLC and mass spectrometry. COA documentation is provided with every order.
⚠FOR RESEARCH USE ONLY — NOT FOR HUMAN OR ANIMAL CONSUMPTION
This compound is supplied exclusively for scientific research by qualified professionals. Any use outside controlled laboratory environments is prohibited. Purchasers are responsible for ensuring compliance with institutional, state, and federal regulations.
